Testing a new pneumonia vaccine in healthy Chinese infants
Part of Infections clinical trials.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be healthy and born after at least 37 weeks of pregnancy.
- Your baby should be around 2 months old (between 42 and 98 days) when the study starts.
- Your baby must not have had a severe allergic reaction to any vaccine before.
- Your baby must not have a significant neurological disorder, seizures, or serious chronic medical conditions.
- Your baby must not have a known or suspected immune system problem.
- Your baby must not have previously received any pneumococcal vaccine or plan to receive one during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
This study tests a new pneumococcal vaccine (PCV24) for babies ages 2 to 23 months. It aims to see if the vaccine is safe and helps protect against serious infections like pneumonia and meningitis.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.
This study tests an experimental pneumococcal vaccine in healthy infants. It involves three shots during infancy and a booster around 12-15 months to see if it is safe and how the body responds.
Hear when a new Pneumococcal Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.